The effect of oxidative stress on accumulation of apolipoprotein E3 and E4 in a cell culture model of beta-amyloid angiopathy (CAA). (Q44546954)

4 December 2017

The effect of oxidative stress on accumulation of apolipoprotein E3 and E4 in a cell culture model of beta-amyloid angiopathy (CAA). (English)

1 reference

4 December 2017

4

1 reference

4 December 2017

Bozena Mazur-Kolecka

1

1 reference

4 December 2017

Dagmar Kowal

series ordinal

2

1 reference

4 December 2017

Tirasak Sukontasup

series ordinal

3

1 reference

4 December 2017

Janusz Frackowiak

series ordinal

5

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

4 December 2017

1 reference

4 December 2017

983

1 reference

4 December 2017

48-57

1 reference

4 December 2017

1-2

1 reference

Oxidative modification of apolipoprotein E in human very-low-density lipoprotein and its inhibition by glycosaminoglycans.

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

Colocalization of lysosomal hydrolase and beta-amyloid in diffuse plaques of the cerebellum and striatum in Alzheimer's disease and Down's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

The apolipoprotein E epsilon4 allele causes a faster decline of cognitive performances in Down's syndrome subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

Medical utility of apoe allele determination in assessing the need for antioxidant therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

Secretion and accumulation of Alzheimer's beta-protein by cultured vascular smooth muscle cells from old and young dogs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

Secretion and accumulation of Abeta by brain vascular smooth muscle cells from AbetaPP-Swedish transgenic mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

Intraneuronal Abeta42 accumulation in human brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

Apolipoprotein E polymorphism in patients with different neurodegenerative disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

Alzheimer's disease, beta-amyloid protein and zinc

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

Differential oxidation of apolipoprotein E isoforms and interaction with phospholipids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

Small vessel disease and Alzheimer's dementia: pathological considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

Electrophoretic analysis of oxidative modification of apolipoprotein E in very low density lipoprotein from fresh human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

Iron overload diminishes atherosclerosis in apoE-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

Lipoproteins in the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

Apolipoprotein E modulates Alzheimer's Abeta(1-42)-induced oxidative damage to synaptosomes in an allele-specific manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

Vulnerability of synaptosomes from apoE knock-out mice to structural and oxidative modifications induced by A beta(1-40): implications for Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

Copper, iron and zinc in Alzheimer's disease senile plaques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

Apolipoprotein E: far more than a lipid transport protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

TGFbeta1 enhances formation of cellular Abeta/apoE deposits in vascular myocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

Factors produced by activated macrophages reduce accumulation of Alzheimer's beta-amyloid protein in vascular smooth muscle cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

Oxidative protein damage in cells engaged in beta-amyloidosis is related to apoE genotype.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

Apolipoprotein E alters metabolism of AbetaPP in cells engaged in beta-amyloidosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

Apolipoproteins E3 and E4 induce, and transthyretin prevents accumulation of the Alzheimer's beta-amyloid peptide in cultured vascular smooth muscle cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

Relationship between severe amyloid angiopathy, apolipoprotein E genotype, and vascular lesions in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

Reactive Oxygen Species Mediate Cellular Damage in Alzheimer Disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

Apolipoprotein E, smooth muscle cells and the pathogenesis of cerebral amyloid angiopathy: the potential role of impaired cerebrovascular A beta clearance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

Oxidative insults are associated with apolipoprotein E genotype in Alzheimer's disease brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

Apolipoprotein E and Alzheimer disease: an update on genetic and functional analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

In Situ Oxidative Catalysis by Neurofibrillary Tangles and Senile Plaques in Alzheimer’s Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

Onset of dementia is associated with apolipoprotein E epsilon4 in Down's syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

Elevated plasma amyloid beta-peptide 1-42 and onset of dementia in adults with Down syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

Prevalence of dementia of Alzheimer type and apolipoprotein E phenotypes in aged patients with Down's syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

Iron accumulation in Alzheimer disease is a source of redox-generated free radicals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

Two types of sporadic cerebral amyloid angiopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

Molecular biology of apolipoprotein E.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

Apolipoprotein E genotyping by one-stage PCR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

The origin of amyloid in cerebral vessels of aged dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

In vitro production of beta-amyloid in smooth muscle cells isolated from amyloid angiopathy-affected vessels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903026-9

10.1016/S0006-8993(03)03026-9

7 January 2021

Identifiers

DOI

1 reference

4 December 2017

1 reference